At the meantime, our study established receiver operating characteristic (ROC) analysis for the first time to evaluate the frequency of CD4+GranzB+CTLs as the prognostic parameters in differentiating whether pSS patients have extraglandular manifestations or not. This evidence concerns the gene CD4 and peeling skin syndrome.